Kestrel Therapeutics

📍 Boston, United States👥 22 employees💰 Last funded Dec 2021
Biotechnology🌐 kestreltherapeutics.com
Website LinkedIn
Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS. We rely on exceptional science, and our focus, always, is on patients.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Kestrel Therapeutics?
Kestrel Therapeutics has 1 investors on record on gritt.io.
When did Kestrel Therapeutics last raise funding?
The most recent investment in Kestrel Therapeutics recorded on gritt.io was in December 2021.
What industry is Kestrel Therapeutics in?
Kestrel Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Kestrel Therapeutics based?
Kestrel Therapeutics is headquartered in Boston, United States.